X4 Pharmaceuticals Inc’s recent filing unveils that its President and CEO Ragan Paula unloaded Company’s shares for reported $17926.0 on Oct 15 ’24. In the deal valued at $0.56 per share,31,897 shares were sold. As a result of this transaction, Ragan Paula now holds 1,025,816 shares worth roughly $0.53 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Ragan Paula bought 31,897 shares, generating $17,862 in total proceeds.
Before that, Mostafa Adam S. sold 230,645 shares. X4 Pharmaceuticals Inc shares valued at $126,901 were divested by the Chief Financial Officer at a price of $0.55 per share. As a result of the transaction, Mostafa Adam S. now holds 0 shares, worth roughly $0.0.
B. Riley Securities downgraded its X4 Pharmaceuticals Inc [XFOR] rating to a Neutral from a a Buy in a research note published on December 12, 2023; the price target was decreased to $1 from $3. Cantor Fitzgerald began covering XFOR with “an Overweight” recommendation on December 22, 2022. Piper Sandler started covering the stock on December 12, 2022. It rated XFOR as “an Overweight”.
Price Performance Review of XFOR
On Friday, X4 Pharmaceuticals Inc [NASDAQ:XFOR] saw its stock jump 3.76% to $0.52. Over the last five days, the stock has gained 6.79%. X4 Pharmaceuticals Inc shares have fallen nearly -38.10% since the year began. Nevertheless, the stocks have fallen -30.93% over the past one year. While a 52-week high of $1.60 was reached on 04/03/24, a 52-week low of $0.47 was recorded on 10/10/24. SMA at 50 days reached $0.6141, while 200 days put it at $0.8635.
Levels Of Support And Resistance For XFOR Stock
The 24-hour chart illustrates a support level at 0.5001, which if violated will result in even more drops to 0.4812. On the upside, there is a resistance level at 0.5388. A further resistance level may holdings at 0.5586. The Relative Strength Index (RSI) on the 14-day chart is 43.86, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0043, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 62.61%. Stochastics %K at 31.38% indicates the stock is a holding.
How much short interest is there in X4 Pharmaceuticals Inc?
A steep rise in short interest was recorded in X4 Pharmaceuticals Inc stocks on 2024-10-15, dropping by -0.96 million shares to a total of 12.66 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 13.62 million shares. There was a decline of -7.61%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on December 23, 2019 when Oppenheimer began covering the stock and recommended ‘”an Outperform”‘ rating along with a $20 price target.
